2016

The chemical composition of fucoidan, a kind of sulfated polysaccharide mainly derived from brown seaweed, includes a substantial percentage of L-fucose. Fucoidan has various biological and pharmacological activities, such as anti-cancer/anti-tumor, anti-proliferation, anti-inflammatory and immune-m …

AbstractObjectives. Chronic gastritis is observed in almost half world population. Traditional medications against chronic gastritis might produce adverse effec

Cancer cachexia is characterized by anorexia, skeletal muscle atrophy, and systemic inflammation. Fucoidan extracted from brown algae exhibits anti-inflammatory and anticancer activities. However, whether fucoidan ameliorates tumour and chemotherapy-induced muscle atrophy and -related cachectic symp …

Chronic kidney disease (CKD) is a common global progressive disease, but there are no ideal drugs for the treatment. Fucoidan and fucoxanthin, and L-c…

Cardiovascular diseases (CVD) are the first cause of death in Mexican population. Metabolic disruptions induced by diet are, in turn, associated with ..

Fucoidan, a fucose-containing sulfated polysaccharide with diverse biological functions, is mainly recovered from brown algae. In this study, we utilized a compressional-puffing process (CPP) to pretreat Sargassum crassifolium (SC) and extracted fucoidans from SC by warm water. Three fucoidan extracts (SC1: puffing at 0 kg/cm2; SC2: puffing at 1.7 kg/cm2; and SC3: puffing at 6.3 kg/cm2) were obtained, and their composition, and antioxidant and neuroprotective activities were examined. The results suggest that CPP decreased the bulk density of algal samples, expanded the algal cellular structures, and eliminated the unpleasant algal odor. The extraction yields of fucoidans were increased and impurities of fucoidans were decreased by increasing the pressures used in CPP. The SC1–SC3 extracts displayed various characteristics of fucoidan as illustrated by the analyses of composition, Fourier transform infrared (FTIR) spectroscopy, and molecular weight. All three extracts SC1–SC3 showed antioxidant activity dose-dependently. Although both SC1 and SC2 possessed high and similar neuronal protective properties, SC2 showed a higher extraction yield, higher efficacy in the reversion of H2O2-induced cytotoxicity in rat pheochromocytoma PC-12 cells, and lower impurities compared with SC1, and thus SC2 is suggested as a good candidate for a therapeutic agent in the preventive treatment of neurodegenerative diseases.

Surface biofunctional modification of cardiovascular stents is a versatile approach to reduce the adverse effects after implantation. In this work, a …

The marine origin polysaccharide fucoidan combines multiple biological activities. As demonstrated by various studies in vitro and in vivo, fucoidans show anti-viral, anti-tumor, anti-oxidant, anti-inflammatory and anti-coagulant properties, although the detailed molecular action remains to be eluci …

Emerging evidence shows that dietary fucoidan contribute to the prevention and treatment of diverse diseases. Here, using a mouse model, we first demo…

Emerging evidence shows that dietary fucoidan contribute to the prevention and treatment of diverse diseases. Here, using a mouse model, we first demo…

Recently, fucoidan has been proposed as a potential prebiotic agent for functional food and pharmaceutical development. However, while previous studies illustrated favorable modulations of gut microbiota by fucoidan, changes in the overall microbial structure remain elusive. In the present study, modulations

Cyclophosphamide (cy) is a widely used cancer drug. Many researchers have focused on the prevention and alleviation of its side effects, particularly damage to the intestinal mucosal barrier. In this study, we examined the effects of fucoidan, isolated from Acaudina molpadioides, on mice with intestinal muco

The key difference between fucoidan and fucoxanthin is that fucoidan is a fucose-containing sulfated polysaccharide present in different species of brown a

Introduction: The world has witnessed a global trend of increasing obesity, which is directly linked to non-communicable diseases, such as type 2 diabetes (T2D). The epidemic of obesity is largely associated with consumption of high calorie diets and low physical activity. Food choice and exercise have a big impact to prevent obesity and T2D making these diseases highly related to personal lifestyle. The diet is one of the most important modifiable lifestyle factors that may be used to prevent obesity. Nopal (Opuntia Ficus Indica) is a cactus plant that has its origin in Mexico and has been used as traditional medicine to prevent overweight and obesity. Since Nopal cladodes are rich in several bioactive compounds, it may be considered as a functional food. The objective of this study was to investigate the perceived effect of Nopal cladodes on appetite variables in healthy humans. Method: Two test-products with two different fractions of Nopal cladodes flour (soluble Nopal fraction bread (SNB) and insoluble Nopal fraction bread (INB)) and a control product (white wheat bread (WB)) were studied in healthy young volunteers (n=17). The subjective appetite variables (hunger, satiety and desire to eat) were measured repeatedly by using a Visual Analog Scale (VAS) during a time perspective of three hours post consumption. Results: The INB resulted in significantly improved response in appetite variables (p < 0.05) compared to the WB. After consumption of the INB, the feeling of hunger and desire to eat were reduced by 27% and 32% respectively, while the feeling of satiety was increased by 25% during the period between 15-180 min post consumption. Importantly, the INB test product also resulted in a significant reduction on hunger and desire to eat, and an increased feeling of satiety during the final hour (120-180 min), compared to the control WB. Conclusion: The results indicate that the insoluble fraction of Nopal flour may beneficially affect appetite variables in healthy young adults. The results thus suggest that Nopal may help to modulate food intake and therefore contribute to antidiabetic effects previously observed with this edible plant.

Fucoidan, a sulfated polysaccharide present in marine brown seaweed, has been demonstrated to inhibit in vivo and in vitro growth of cells. The present study was conducted in HT‑29 human colon cancer cells cultured at a high density, and examined the potential underlying mechanisms by which fucoidan exerts its anti‑proliferative effects, which remain poorly understood. Fucoidan treatment of high‑density HT‑29 cells resulted in the inhibition of cell growth and increased apoptotic cell death. Flow cytometric analysis revealed that fucoidan treatment led to sub‑G1 phase cell cycle arrest. This was associated with decreased protein expression levels of Retinoblastoma protein and E2 factor protein. In conclusion, the results of the present study demonstrated that fucoidan possesses anticancer activity against high density HT‑29 cells by inhibiting cell growth and cell cycle progression.

Dr. Jennifer Kohler, Associate Professor at the University of Texas Southwestern Medical Center, speaks about her research in intestinal fucose. The Joint Webinar Series is a collaborative effort by GlycoNet and American Chemical Society's Carbohydrate Chemistry Division. The series is sponsored by New England Biolabs. To learn more, visit http://bit.ly/glycowebinar

Effect and mechanism of laminaria japonica polysaccharide (LJP) on apoptosis and cycle of nasopharyngeal carcinoma cells, Fugui Wei, Xunxun Lu, Ying Lin, Min Guo, Wenzhong Sun

Fucoidan was purified from seaweed, Turbinaria conoides. Isolated fragments were characterized with NMR (13C, 1H), Gas Chromatography–Mass Spectronomy…

Ho Park, and Beom-Su Kim. Korean J Clin Lab Sci. 2017;49:323-8. https://doi.org/10.15324/kjcls.2017.49.4.323

The presence of pesticide residues in vegetable and fruit products, as a consequence of inappropriate application in some cases, constitutes a risk to the health of the exposed population. In Mexico, the official norm, NOM-003-STPS-1999, only allows the use of pesticides with the phytosanitary registry, the responsible state commission for the control of the process and use of pesticides and toxic substances, which recommends doses and permitted crops. Despite the above, it is still common to find pesticide residues in some vegetable products. In this study, the following were detected: Chlorpyriphos, Dimetomorph I, Malathion, Omethoate, Carbendazim, and Imidacloprid in Nopal. The study was carried out in two collection centers located in the state of Morelos. In total, sixty samples were taken, thirty for each collection center, for a period of 10 months. To determine the pesticide residues, the analytical methodology was used, according to the guide, SANTE/11945/2015; in a laboratory accredited by the Mexican Accreditation Entity A. C. in the norm, NMX-EC-17025-IMNC-2006. The procedure for extracting analytes was carried out using the method, QuEChERS. The highest concentration of the pesticides detected in the samples obtained from the non-Certified Supply Center were Chlorpyrifos 0.309 mg/kg (MRL 0.01), Dimetomorf I 0.029 mg/kg (MRL 0.01), Malathion 0.155 mg/kg (MRL 0.01), Omethoate 0.032 (MRL 0.01), Carbendazim 0.090 mg/kg (MRL 0.01), and Imidacloprid 0.058 mg/kg (MRL 0.01). Thirty percent of the samples analyzed showed pesticide residues; the most frequent were Carbendazim. The results for the estimated daily intake (EDI) oscillated between 6.5 &times; 10&minus;5 and 1.3 &times; 10&minus;4 mg/kg body weight for the vegetable, Nopal. In principle, it could be concluded that the consumption of Nopal with pesticide residues does not represent any toxicological risk for human health, however, the risk cannot be ruled out due to the intake of other vegetables and fruits that are cultivated in the Mexican Republic, which probably present pesticide residues, which together would raise potential risks to human health.

Background: Alcoholic liver disease is caused as a result of chronic alcohol consumption. In this study, we used an alcoholic liver injury mouse model to investigate the effect of fucoidan on ethanol-induced liver injury and steatosis and the underlying mechanisms. Methods: All mice were randomly divided into four groups: 1) control group, 2) model group, 3) diammonium glycyrrhizinate treatment group (200 mg/kg body weight), and 4) fucoidan treatment group (300 mg/kg body weight). Administration of ethanol for 8 weeks induced liver injury and steatosis in mice. Results: Fucoidan treatment decreased serum alanine aminotransferase activity, serum total cholesterol levels, and hepatic triglyceride levels, and improved the morphology of hepatic cells. Fucoidan treatment upregulated the expression of AMPKα1, SIRT1, and PGC-1α and inhibited the expression of ChREBP and HNF-1α. The levels of hepatic IL-6 and IL-18 were significantly decreased in the fucoidan group. Further, the levels of cytochrome P450-2E1 (CYP2E1), glucose-regulated protein (GRP) 78, and 3-nitrotyrosine (3-NT) in hepatic tissues were reduced in the fucoidan group as compared to the model group. Fucoidan significantly reversed the reduction of ileac Farnesoid X receptor (FXR) and fibroblast growth factor 15 (FGF15) levels induced by alcohol- feeding and reduced CYP7A1 (cholesterol 7α-hydroxylase) expression and total bile acid levels in the liver tissue. In addition, fucoidan regulated the structure of gut flora, with increased abundance of Prevotella and decreased abundance of Paraprevotella and Romboutsia as detected by 16S rDNA high-throughput sequencing. Conclusion: Fucoidan inhibited alcohol-induced steatosis and disorders of bile acid metabolism in mice through the AMPKα1/SIRT1 pathway and the gut microbiota–bile acid–liver axis and protected against alcohol- induced liver injury in vivo.

Fucoidan is an effective antitumor agent, either alone or in combination with cisplatin, doxorubicin and taxol in MCF-7 breast cancer cells. Drug combinations that discriminate between cancerous and non-cancerous cells afford a plausible and viable strategy of attaining therapeutic efficacy and avoi …

Preliminary investigation of a fucoidan with demonstrated reduction in the symptoms of osteoarthritis (OA) of the hip and knee.A double-blind randomized controlled trial was carried out to determine the safety and efficacy of a 300 mg dose of a Fucus ...

(2018). Effects of fucoidan on diabetic rat testicular tissue. Biotechnic & Histochemistry: Vol. 93, No. 4, pp. 277-285.

This work determines the effect nopal consumption at different maturity stages (60, 200, 400, and 600 g) as the only calcium source in bone metabolism. The apparent mineral absorption, the biomarkers of bone metabolism, the bone mineral density at different femoral regions, and crystal properties of the bone were evaluated during the growth stage. The Ca absorption was increased with the rat age in most of the experimental groups, while Mg supplementation decreased intestinal absorption probably due to a saturation process. Intestinal Ca and Mg absorption showed an opposite trend; this result suggests that both ions can compete for vitamin D absorption sites. The percentage of absorption of K was lower in the groups fed with Nopal; nevertheless, due to supplementation, the net absorption was higher than the control group. In all groups, osteocalcin levels decreased with the rat age. Nopal consumption increased osteocalcin levels during the adolescence stage in comparison to the control group. Amino N-terminal propeptide of type I procollagen levels increased in puberty and adolescence in all groups compared to the control group. Bone mineral density in different femoral regions was lower in the groups fed with nopal at early maturity stages (N-60 and N-200) than the groups fed with nopal at late maturity stages (N-400 and N-600). The crystal size of hydroxyapatite exhibited changes for all the groups, indicating the inclusion of mono and divalent ions in calcium replacement. On this basis, the nopal at late maturity stage contributed to bone formation.

Colorectal cancer (CRC) is one of the major malignancies in humans. This study was designed to evaluate the effects of fucoidan on gut flora and tumor…

Objective. To investigate the effect of Laminaria japonica polysaccharides (LJP) on the survival of non-small-cell lung cancer (NSCLC) A549 cells and its mechanism. Methods. In vitro: the cells were randomly divided into control group, LJP (5 mg/ml) group, LJP (10 mg/ml) group, and LJP (20 mg/ml) group. After corresponding treatment, the survival rate and the expression of proteins related to proliferation, apoptosis, epithelial-mesenchymal transition (EMT), and signaling pathway were detected by CCK8 assay and Western blot, respectively. In vivo: a xenograft model was established to detect the tumor volume and mass and the expression of the above pathway proteins. Results. Compared with the control group, LJP decreased the survival rate of A549 cells (), inhibited the protein expression of Ki67 and PCNA (), downregulated the expression of Bcl-2 while upregulated the expression of Bax, cl-caspase-3, and cl-caspase-9 (), upregulated the expression of E-cadherin, downregulated the expression of vascular endothelial growth factor (VEGF) and N-cadherin (), and downregulated β-catenin, transcription factor-4 (TCF4), and c-Myc protein expression levels (). In vivo: LJP decreased the volume and mass of the xenograft tumors and downregulated β-catenin, TCF4, and c-Myc protein expression levels compared with the control group (). Conclusion. LJP can inhibit the survival of non-small-cell lung cancer A549 cells in vitro, and its mechanism is related to the inhibition of activation of β-catenin/TCF4 pathway activation.